Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698583 | Clinical Oncology | 2015 | 10 Pages |
Abstract
Decreasing treatment volumes from IFRT to ISRT, INRT or residual volume reduces radiation exposure to OARs. Second malignancy modelling suggests that this reduction in treatment volumes will lead to a reduction in absolute excess second malignancy. Little difference was observed in second malignancy risks between ISRT and INRT, supporting the use of ISRT in the absence of a pre-chemotherapy positron emission tomography scan in the radiotherapy treatment position.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Murray, B. Sethugavalar, H. Robertshaw, E. Bayman, E. Thomas, D. Gilson, R.J.D. Prestwich,